ArticleOncotarget2019
Assessment of soluble immune mediators as potential biomarkers during immune checkpoint inhibitor therapy.
Norikazu Matsuo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it